Cryo-Save plans to list on Euronext

September 3, 2009 Group News

Cryo-Save Group N.V. (AIM: CRYO, “Cryo-Save”), Europe’s leading stem cell bank, plans to seek an additional listing on Euronext Amsterdam in the fourth quarter of the current financial year to complement the Group’s shares being traded on AIM in London. Cryo-Save was admitted to trading on AIM on 6 November 2007.

Cryo-Save intends to review the need to maintain the AIM listing in early 2010.

Cryo-Save expects to make further announcements with regards to the Euronext listing in due course.

Marc Waeterschoot, Chief Executive, commented:

We are looking to become listed on Euronext in Amsterdam. Being a Dutch company, with most of our business on the continent, a local listing should increase our visibility as well as liquidity.



For further details

Cryo-Save Group
+ 31 (0) 575 548 998
Marc Waeterschoot, Chief Executive
Arnoud van Tulder, Chief Financial Officer

Daniel Stewart & Company plc
+ 44 (0) 20 7776 6550
Simon Leathers/Charlotte Stranner

College Hill
+ 44 (0) 20 7457 2020
Adrian Duffield/Rozi Morris

Related Articles